GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹2,798 Cr | ₹2,494 Cr | ₹3,708 Cr | ₹2,023 Cr | ₹1,775 Cr |
What is the latest Total Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹2,798 Cr |
Mar2023 | ₹2,494 Cr |
Mar2022 | ₹3,708 Cr |
Mar2021 | ₹2,023 Cr |
Mar2020 | ₹1,775 Cr |
How is Total Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹2,798 Cr | 12.19 | |
Mar2023 | ₹2,494 Cr | -32.73 | |
Mar2022 | ₹3,708 Cr | 83.33 | |
Mar2021 | ₹2,023 Cr | 13.96 | |
Mar2020 | ₹1,775 Cr | - |
Compare Total Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹48,238.3 Cr | -3.8% | 2.6% | 35% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,406.0 Cr | -2.7% | 3.9% | 19.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,113.0 Cr | 1% | 8.5% | 55.3% | Stock Analytics | |
CIPLA | ₹121,869.0 Cr | -2.6% | 3.9% | 6.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,345.0 Cr | -0.7% | 2.5% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,801.0 Cr | -1.9% | 0.9% | -7.8% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -3.8% |
2.6% |
35% |
SENSEX | 0.6% |
6.2% |
8.4% |
You may also like the below Video Courses